Novartis is pulling back the…
Novartis is pulling back the curtain on late-stage Sjögren’s wins, [...]
Eli Lilly and computing giant…
Eli Lilly and computing giant Nvidia are teaming up to [...]
Edesa Biotech has shared data from…
Edesa Biotech has shared data from its truncated phase 3 [...]
Aldeyra Therapeutics has shaken up…
Aldeyra Therapeutics has shaken up its drug development pipeline, stopping [...]
The number of biopharma M&A…
The number of biopharma M&A deals announced so far this [...]
Intellia Therapeutics has…
Intellia Therapeutics has temporarily paused dosing and screening in a [...]
Zenas Biopharma’s lead…
Zenas Biopharma’s lead autoimmune drug has been tied to a [...]
Almost a year after buying Kate…
Almost a year after buying Kate Therapeutics, Novartis has scooped [...]
Just as Adverum’s cash reserves…
Just as Adverum’s cash reserves were running dry, Eli Lilly [...]
Biogen plans to beef up its…
Biogen plans to beef up its early-stage immunology pipeline by [...]